The New Walgreens Boots Alliance, Inc Holding in Amerisourcebergen Corp
Walgreens Boots Alliance, Inc filed with the SEC SC 13D/A form for Amerisourcebergen Corp. The form can be accessed here: 000119312516767891. As reported in Walgreens Boots Alliance, Inc’s form, the filler as of late owns 25.8% or 56,854,867 shares of the Consumer Staples–company.
Amerisourcebergen Corp stake is a new one for the and it was filed because of activity on November2, 2016. We feel this shows Walgreens Boots Alliance, Inc’s positive view for the stock.
Reasons Why Walgreens Boots Alliance, Inc Bought – Amerisourcebergen Corp Stock
Purpose of Transaction
Item4 is amended and supplemented as follows:
Based on the number of shares of Common Stock held by WBA Holdings and the number of shares of Common Stock outstanding as of the date of thisAmendment No.5, further regulatory approval would be required under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”) in order for WBA Holdings to acquire additional shares of Common Stock. TheReporting Persons would seek required regulatory approvals in advance of any future transaction requiring such approval. However, no decisions have been made regarding future transactions, if any, or their timing. Those determinations will dependupon various factors described in the original Schedule 13D, including market conditions and other factors.
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers. Servicing healthcare providers in the pharmaceutical supply channel, the Pharmaceutical Distribution segment’s operations provide drug distribution and related services. The Other segment consists of the operations of various segments, including the AmerisourceBergen Consulting Services (ABCS), the World Courier Group, Inc. and the MWI Veterinary Supply, Inc. ABSG operates distribution facilities that focus primarily on complex disease treatment regimens.
SEC Form 13D is filed within 10 days, by anyone who acquires beneficial ownership of 5%+ of any public firm. Activist investors and practices such as: company breakups, hostile takeovers, and change of control events, are permitted for this form filers. A filer must promptly update its 13D filing in case of acquisition or disposition of 1% or more of the securities that are the subject of the filing.
The stock increased 3.05% or $2.41 during the last trading session, hitting $81.33. About 4.40 million shares traded hands or 37.93% up from the average. AmerisourceBergen Corp. (NYSE:ABC) has declined 7.04% since April 12, 2016 and is downtrending. It has underperformed by 12.03% the S&P500.
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The company has a market cap of $19.18 billion. The Company’s divisions include Pharmaceutical Distribution and Other. It has a 12.83 P/E ratio. The Firm provides services to healthcare providers, and pharmaceutical and biotech manufacturers.
AmerisourceBergen Corp. (NYSE:ABC) Ratings Coverage
Out of 15 analysts covering AmerisourceBergen (NYSE:ABC), 7 rate it a “Buy”, 0 “Sell”, while 8 “Hold”. This means 47% are positive. $130 is the highest target while $83 is the lowest. The $99.23 average target is 22.01% above today’s ($81.33) stock price. AmerisourceBergen has been the topic of 30 analyst reports since July 27, 2015 according to StockzIntelligence Inc. The stock of AmerisourceBergen Corp. (NYSE:ABC) earned “Underweight” rating by Morgan Stanley on Friday, October 2. The firm has “Buy” rating given on Thursday, August 27 by Zacks. The firm earned “Outperform” rating on Friday, February 5 by RBC Capital Markets. UBS maintained AmerisourceBergen Corp. (NYSE:ABC) on Friday, February 5 with “Buy” rating. RBC Capital Markets maintained the stock with “Outperform” rating in Friday, May 6 report. The rating was upgraded by TheStreet to “Buy” on Monday, July 27. The stock has “Mkt Perform” rating given by FBR Capital on Thursday, February 4. The firm has “Neutral” rating given on Tuesday, June 7 by Bank of America. The firm earned “Neutral” rating on Wednesday, November 18 by Mizuho. The rating was upgraded by Zacks to “Hold” on Tuesday, August 25.
More news for AmerisourceBergen Corp. (NYSE:ABC) were recently published by: Wsj.com, which released: “AmerisourceBergen Reports Revenue Growth” on November 02, 2016. Businesswire.com‘s article titled: “AmerisourceBergen Increases Dividend 7 Percent” and published on November 10, 2016 is yet another important article.
According to Zacks Investment Research, “AmerisourceBergen Corporation provides pharmaceutical services. It distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers. The Company also provides pharmacy services to certain specialty drug patients. AmerisourceBergen Corporation is based in Chesterbrook, Pennsylvania.”
ABC Company Profile
AmerisourceBergen Corporation, incorporated on March 16, 2001, is a pharmaceutical sourcing and distribution services company. The Company’s divisions include Pharmaceutical Distribution and Other. The Firm provides services to healthcare providers, and pharmaceutical and biotech manufacturers.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.